HCA Holdings, Inc. announced consolidated earnings and operating results for the fourth quarter and year ended December 31, 2016. For the quarter, the company reported revenues in the fourth quarter totaled $10.641 billion, compared to $10.249 billion in the fourth quarter of 2015. Net income attributable to HCA Holdings, Inc. totaled $920 million, or $2.39 per diluted share, compared to $582 million, or $1.40 per diluted share, in the fourth quarter of 2015. Income before income taxes was $1.565 billion against $1.052 billion a year ago. Adjusted EBITDA increased 3.6% to $2.206 billion compared to $2.131 billion in the prior year period. Capital expenditures totaled $876 million, excluding acquisitions, in the fourth quarter. Net cash provided by operating activities in the fourth quarter of 2016 totaled $1.699 billion compared to $1.558 billion in the prior year's fourth quarter. Net income attributable to HCA Holdings, Inc., excluding losses (gains) on sales of facilities, losses on retirement of debt and legal claim costs was $729 million or $1.89 per diluted share against $701 million or $1.69 per diluted share a year ago.

For the year ended December 31, 2016, revenues totaled $41.490 billion compared to $39.678 billion for 2015. Net income attributable to HCA Holdings, Inc. for 2016 was $2.890 billion, or $7.30 per diluted share, compared to $2.129 billion, or $4.99 per diluted share, for the year ended December 31, 2015. Income before income taxes was $4.810 billion against $3.957 billion a year ago. Adjusted EBITDA for 2016 increased to $8.218 billion compared to $7.915 billion in 2015. Net cash provided by operating activities was $5.653 billion compared to $4.734 billion in 2015. Purchase of property and equipment was $2.76 billion compared to $2.375 billion in 2015. For the full year 2016, diluted earnings per share, excluding gains and losses on sale of facilities and losses on retirement of debt and legal claims benefit costs, increased 23.6% over full year 2015. Net income attributable to HCA Holdings, Inc., excluding losses on sales of facilities, losses on retirement of debt and legal claim costs was $2,718 million or $6.87 per diluted share against $2,375 million or $5.56 per diluted share a year ago.

For the quarter, the company reported number of hospitals was 170 against 168 a year ago. Number of freestanding outpatient surgery centers was 118 against 116 a year ago. Occupancy was 56.7% against 56.8% a year ago.

For the year, the company reported number of hospitals was 170 against 168 a year ago. Number of freestanding outpatient surgery centers was 118 against 116 a year ago. Occupancy was 57.5% against 57.5% a year ago.

For the year ending December 31, 2017, the company expects revenues will be in the range of $43.0 billion to $44.0 billion, adjusted EBITDA will be in the range of $8.40 to $8.70 billion, diluted EPS will be in the range of $7.20 to $7.60, capital expenditures will be approximately $2.9 billion. Within revenue estimates, the company estimates revenue per equivalent admission growth to range between 2% and 3% for 2017. The company estimates depreciation and amortization to be approximately $2.05 billion and interest expense to be approximately $1.7 billion. Effective tax rate is expected to be approximately 34%. The company anticipating cash flow from operations to range somewhere between $5.3 billion and $5.5 billion. And it will be down slightly from this year due to some anticipated increase in cash taxes. Net income attributable to the company in a range of $2.71 billion to $2.86 billion.